Study of FMT Combined With Nivolumab in Gastric Cancer

NCT05001360 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped We could not get the IRB approval.

Conditions

Gastric Adenocarcinoma
Esophagogastric Junction Adenocarcinoma
Esophagus Adenocarcinoma

Interventions

DRUG: XBI-302 + Nivolumab

Sponsor

Fujian Cancer Hospital